Copyright
©The Author(s) 2016.
World J Gastrointest Endosc. Aug 25, 2016; 8(16): 553-557
Published online Aug 25, 2016. doi: 10.4253/wjge.v8.i16.553
Published online Aug 25, 2016. doi: 10.4253/wjge.v8.i16.553
Table 2 Demographics and complications in patients taking clopidogrel vs patients not on clopidogrel
| Outcome | No plavix | Plavix | P value |
| Patients (n) | 286 | 33 | - |
| Age (mean years ± SD) | 64.37 ± 16.44 | 71.21 ± 11.43 | 0.02 |
| BMI (mean years ± SD) | 28.30 ± 9.59 | 29.25 ± 10.66 | 0.60 |
| Hgb drop < 48 h | 5 | 2 | 0.16 |
| Local complications < 48 h | 8 | 2 | 0.28 |
| Transfusions < 48 h | 7 | 2 | 0.24 |
| Rescope < 48 h | 1 | 1 | 0.20 |
- Citation: Sohail U, Harleen C, Mahdi AO, Arif M, Nguyen DL, Bechtold ML. Bleeding risk with clopidogrel and percutaneous endoscopic gastrostomy. World J Gastrointest Endosc 2016; 8(16): 553-557
- URL: https://www.wjgnet.com/1948-5190/full/v8/i16/553.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i16.553